COMPANY PROFILE · UPDATED 18 NOV 2025

Insitro

Insitro is an operator of a data-driven drug discovery and development company that utilizes machine learning and high-throughput biology to transform the way that drugs are discovered and delivered to patients. The company uses…

insitro.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2018
Headcount: 194
Open roles: 14
Last raised: Series C · Sign in to view

TECH STACK

How Insitro builds

LEADERSHIP

Founders & key people

OPEN ROLES

Hiring at Insitro

View all 14 open roles →

FUNDING

Capital raised

Total raised

$643,000,000

Investors

Gv Andreessen Horowitz Softbank Vision FundAlexandria Venture InvestmentsArch Venture PartnersBezos ExpeditionsBlackrockCanada Pension Plan Investment Board (CPPIB)Casdin CapitalForesite CapitalHOF CapitalMubadalaT. Rowe PriceTemasekThird Rock VenturesTwo Sigma VenturesVerilyWuXi AppTec Co.

Funding rounds

Series C
Canada Pension Plan Investment Board (CPPIB), Arch Venture Partners, Andreessen Horowitz, Two Sigma Ventures, Third Rock Ventures, T. Rowe Price, Temasek, Casdin Capital, Foresite Capital, GV, HOF Capital, Blackrock, Alexandria Venture Investments, SoftBank Vision Fund
$400MMar 14, 2021
Series B
Andreessen Horowitz, WuXi AppTec Co., Two Sigma Ventures, Arch Venture Partners, Third Rock Ventures, HOF Capital, Foresite Capital, T. Rowe Price, Canada Pension Plan Investment Board (CPPIB), Blackrock, GV, Alexandria Venture Investments, Casdin Capital
$143MMay 25, 2020
Series A
Foresite Capital, GV, Third Rock Ventures, Andreessen Horowitz, Arch Venture Partners, Alexandria Venture Investments, Two Sigma Ventures, Bezos Expeditions, Verily, Mubadala
$100MMay 1, 2018

Funding data via Diffbot